Biobot Analytics dug into years of wastewater data and found that PMMoV drifted 2 to 3 times between 2022 and 2024.
Published
Signal category
Research & Knowledge
Quote
“Our team dug into years of Biobot's and publicly-available wastewater data and found something important: PMMoV drifted 2–3x between 2022 and 2024.”
— Biobot Analytics team
Company
Biobot Analytics
Biobot transforms wastewater into privacy-first, predictive health intelligence.
- Industry
- Data Infrastructure and Analytics
- Location
- Cambridge, US
- Company size
- 27 employees
Biobot is the pioneer and global leader in wastewater epidemiology, transforming sewage into a real-time public health observatory. Founded out of a research project at MIT, Biobot provided the first detection of SARS-CoV-2 in wastewater in the U.S. in early 2020. Its pioneering work has expanded to monitor dozens of pathogens and high-risk substances across hundreds of communities, fueled by top venture investors and validated by SBIR Phase I, II, and III awards from the NIH. Our first product is to measure opioids and other drug metabolites in sewage to estimate consumption in cities. With this data, those working on harm reduction can assess the scope of the epidemic, allocate resources, and gauge the effectiveness of programming over time.
Founded 2017